Showing results (1091-1100 of 2,583) with videos related to

Sort By:
Pageof 259
Molecular Oncology|May 10, 2020
Human fibronectin extra domain B as a biomarker for targeted therapy in cancerRelinde I Y Lieverse, Damiënne Marcus, Alexander M A van der Wiel, et al.
Molecular Oncology|September 20, 2021
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective studyGui-Qi Zhu, Wei-Ren Liu, Zheng Tang, et al.
Molecular Oncology|March 20, 2023
Engaging European society at the forefront of cancer research and care: How discussions at the 5th Gago Conference on European Science policy led to the Heidelberg ManifestoMichael Baumann, Julio Celis, Ulrik Ringborg, et al.
Molecular Oncology|February 22, 2023
Bicarbonate transport as regulator of antitumour immunity in pancreatic cancerEmily J Kay, Sara Zanivan
Molecular Oncology|February 24, 2023
Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8+ T cellsMengyao Wang, Rundong Zhai, Mengqi Wang, et al.
Molecular Oncology|February 28, 2023
Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLCCaterina Carbonell, Joan Frigola, Nuria Pardo, et al.
Molecular Oncology|February 28, 2023
Improved detection of homologous recombination deficiency in Chinese patients with ovarian cancer: a novel non-exonic single-nucleotide polymorphism-based next-generation sequencing panelBing Wei, Jinxiang Zheng, Cai Jiang, et al.
Molecular Oncology|May 18, 2021
Cancer outcomes research-a European challenge: measures of the cancer burdenMette Kalager, Hans-Olov Adami, Pernilla Lagergren, et al.
Molecular Oncology|May 2, 2021
Systematic analysis of migration factors by MigExpress identifies essential cell migration control genes in non-small cell lung cancerJagriti Pal, Andrea C Becker, Sonam Dhamija, et al.
Molecular Oncology|June 25, 2020
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastropheStanislav Drápela, Prashant Khirsariya, Wytske M van Weerden, et al.
Pageof 259